We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
Cap. Flow
-$4.28B
Cap. Flow %
-30.25%
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98

Sector Composition

Rank Sector Weight
1 Technology 14.91%
2 Healthcare 8.15%
3 Consumer Discretionary 7.49%
4 Financials 7.2%
5 Communication Services 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
276
Fortune Brands Innovations
FBIN
$6.09B
$6.37M 0.05%
116,603
-7,461
-6% -$347K
FE icon
277
FirstEnergy
FE
$28.7B
$6.37M 0.05%
164,178
-10,506
-6% -$434K
NSC icon
278
Norfolk Southern
NSC
$76.1B
$6.33M 0.04%
36,069
-2,308
-6% -$391K
CZR
279
DELISTED
Caesars Entertainment Corporation
CZR
$6.28M 0.04%
518,000
MAA icon
280
Mid-America Apartment Communities
MAA
$15.8B
$6.25M 0.04%
54,503
-6,087
-10% -$686K
DOW icon
281
Dow Inc
DOW
$20.8B
$6.25M 0.04%
153,221
-9,806
-6% -$359K
DGX icon
282
Quest Diagnostics
DGX
$26B
$6.24M 0.04%
54,781
-3,605
-6% -$382K
PEG icon
283
Public Service Enterprise Group
PEG
$39.3B
$6.2M 0.04%
126,147
-8,071
-6% -$402K
O icon
284
Realty Income
O
$61.3B
$6.19M 0.04%
107,380
-6,870
-6% -$366K
TECD
285
DELISTED
Tech Data Corp
TECD
$6.14M 0.04%
42,354
+7,586
+22% +$1.05M
TFX icon
286
Teleflex
TFX
$5.94B
$6.04M 0.04%
16,605
-506
-3% -$175K
ETN icon
287
Eaton
ETN
$150B
$6.04M 0.04%
68,991
-4,415
-6% -$363K
GD icon
288
General Dynamics
GD
$106B
$6.01M 0.04%
40,190
-2,571
-6% -$363K
KHC icon
289
Kraft Heinz
KHC
$32.4B
$6M 0.04%
188,259
-12,047
-6% -$362K
BMRN icon
290
CALL
BioMarin Pharmaceuticals
BMRN
$12B
$5.92M 0.04%
+48,000
New +$4.77M
WU icon
291
Western Union
WU
$2.58B
$5.9M 0.04%
272,698
-17,450
-6% -$354K
CME icon
292
CME Group
CME
$93.5B
$5.89M 0.04%
36,251
-2,316
-6% -$415K
MNST icon
293
Monster Beverage
MNST
$95.6B
$5.86M 0.04%
169,176
-10,824
-6% -$353K
PSA icon
294
Public Storage
PSA
$61.7B
$5.76M 0.04%
30,013
-1,920
-6% -$370K
INSP icon
295
Inspire Medical Systems
INSP
$1.5B
$5.76M 0.04%
66,167
+4,532
+7% +$348K
VLO icon
296
Valero Energy
VLO
$88.7B
$5.7M 0.04%
96,947
+29,723
+44% +$1.78M
WMS icon
297
Advanced Drainage Systems
WMS
$11.1B
$5.63M 0.04%
114,030
-3,442
-3% -$141K
SWKS icon
298
Skyworks Solutions
SWKS
$9.73B
$5.63M 0.04%
44,000
ACC
299
DELISTED
American Campus Communities, Inc.
ACC
$5.59M 0.04%
+160,000
New +$5.3M
WELL icon
300
Welltower
WELL
$172B
$5.53M 0.04%
106,782
-63,233
-37% -$3.11M

Similar funds

Calamos Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.

  • Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
  • Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
  • Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
  • Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
  • Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
  • Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
  • Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.

Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.